JK Agri Genetics Limited (BOM:536493)
India · Delayed Price · Currency is INR 301.95
+8.50 (2.90%)
At close: Aug 21, 2026
JK Agri Genetics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,500 | 1,576 | 1,618 | 1,481 | 2,009 | 2,458 | |
Revenue Growth | -14.17% | -2.59% | 9.24% | -26.29% | -18.27% | 9.86% |
Cost of Revenue | 872.65 | 917.14 | 1,009 | 1,005 | 1,231 | 1,335 |
Gross Profit | 627.27 | 658.8 | 608.59 | 475.55 | 778.71 | 1,124 |
Selling, General & Admin | 269.43 | 293.38 | 371.27 | 341.73 | 476.28 | 509.09 |
Other Operating Expenses | 299.05 | 280.37 | 337.49 | 385.81 | 385.56 | 462.18 |
Operating Expenses | 601.67 | 612.42 | 749.1 | 762.19 | 886.41 | 1,006 |
Operating Income | 25.6 | 46.38 | -140.51 | -286.64 | -107.7 | 118 |
Interest Expense | -37.85 | -42.71 | -58.15 | -79.46 | -68.88 | -53.72 |
Interest & Investment Income | 3.38 | 3.38 | 4.37 | 2.62 | 3.01 | 23.11 |
Earnings From Equity Investments | -0 | -0 | -0.04 | - | - | - |
Currency Exchange Gain (Loss) | 0.08 | 0.08 | -0.31 | -0.31 | -0.11 | -0.4 |
Other Non Operating Income (Expenses) | -10.97 | -2.64 | -0.78 | 33.06 | -1.29 | 13.61 |
EBT Excluding Unusual Items | -19.76 | 4.49 | -195.42 | -330.74 | -174.98 | 100.6 |
Gain (Loss) on Sale of Investments | 48.26 | 48.26 | 46.7 | 37.14 | 22.67 | 1.81 |
Gain (Loss) on Sale of Assets | 0.92 | 0.92 | -0.82 | -2.5 | -0.45 | 0.15 |
Asset Writedown | -42.58 | -42.58 | - | - | - | - |
Other Unusual Items | -8.46 | -8.46 | 124.85 | - | - | - |
Pretax Income | -21.62 | 2.63 | -24.69 | -296.09 | -152.76 | 102.56 |
Income Tax Expense | 64.27 | 74.34 | 0.39 | -87.88 | -44.77 | 25.24 |
Net Income | -85.88 | -71.7 | -25.09 | -208.21 | -107.99 | 77.32 |
Net Income to Common | -85.88 | -71.7 | -25.09 | -208.21 | -107.99 | 77.32 |
Net Income Growth | - | - | - | - | - | 7.83% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change | -0.02% | - | - | - | - | 8.02% |
EPS (Basic) | -18.52 | -15.46 | -5.41 | -44.90 | -23.29 | 16.67 |
EPS (Diluted) | -18.52 | -15.46 | -5.41 | -44.90 | -23.29 | 16.67 |
EPS Growth | - | - | - | - | - | -0.17% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -286.95 | -9.08 | 232.69 | 12.46 | -17.24 |
Free Cash Flow Per Share | - | -61.88 | -1.96 | 50.18 | 2.69 | -3.72 |
Dividend Per Share | - | - | - | - | - | 1.500 |
Dividend Growth | - | - | - | - | - | 0% |
Gross Margin | 41.82% | 41.80% | 37.62% | 32.11% | 38.76% | 45.71% |
Operating Margin | 1.71% | 2.94% | -8.69% | -19.36% | -5.36% | 4.80% |
Profit Margin | -5.73% | -4.55% | -1.55% | -14.06% | -5.37% | 3.15% |
Free Cash Flow Margin | - | -18.21% | -0.56% | 15.71% | 0.62% | -0.70% |
EBITDA | 58.82 | 76.23 | -124.15 | -274.09 | -93.09 | 132.26 |
EBITDA Margin | 3.92% | 4.84% | -7.67% | -18.51% | -4.63% | 5.38% |
D&A For EBITDA | 33.22 | 29.84 | 16.36 | 12.55 | 14.61 | 14.26 |
EBIT | 25.6 | 46.38 | -140.51 | -286.64 | -107.7 | 118 |
EBIT Margin | 1.71% | 2.94% | -8.69% | -19.36% | -5.36% | 4.80% |
Effective Tax Rate | - | 2822.21% | - | - | - | 24.61% |
Revenue as Reported | 1,562 | 1,646 | 1,669 | 1,556 | 2,035 | 2,499 |
Advertising Expenses | - | 17.2 | 20.02 | 39.24 | 109.83 | 117.74 |